Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyra O'Brien

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of General Internal Medicine|September 27, 2022
A Roadmap for Modifying Clinician Behavior to Improve the Detection of Cognitive ImpairmentKyra O'Brien, Robert Burke, Jason Karlawish
JAMA|July 30, 2025
Communicating a Diagnosis of Mild Cognitive Impairment or DementiaKyra O'Brien, Emily A Largent, Jason Karlawish
Journal of the American Geriatrics Society|July 17, 2025
An Elusive Ideal-Why a Pragmatic "Home Time" Quality Measure Remains Hard to DefineKyra O'Brien, Robert E Burke, Debra Saliba
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 31, 2024
Applying recommendations for diagnostic disclosure of mild cognitive impairment and dementia: Practical guidance for cliniciansKyra O'Brien, Emily A Largent, Jason Karlawish
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthKyra O'Brien, Wheeler Maxwell, Robert Burke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersAbigail Perelman, Megan Zhang, Cameron Coykendall, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersMegan Zhang, Abigail Perelman, Cameron Coykendall, et al.
Neurology|January 31, 2023
Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease ContinuumEmily A Largent, Joshua D Grill, Kyra O'Brien, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 8, 2026
Study of the utility and impact of a plasma p-tau181 Alzheimer's biomarker (SUITABLE)Kyra O'Brien, Cameron Coykendall, Kristin Harkins, et al.
Journal of General Internal Medicine|January 3, 2024
Determinants of Plasma Alzheimer's Disease Biomarker Use by Primary Care Providers and Dementia SpecialistsKyra O'Brien, Cameron Coykendall, Melanie Kleid, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of General Internal Medicine|September 27, 2022
A Roadmap for Modifying Clinician Behavior to Improve the Detection of Cognitive ImpairmentKyra O'Brien, Robert Burke, Jason Karlawish
JAMA|July 30, 2025
Communicating a Diagnosis of Mild Cognitive Impairment or DementiaKyra O'Brien, Emily A Largent, Jason Karlawish
Journal of the American Geriatrics Society|July 17, 2025
An Elusive Ideal-Why a Pragmatic "Home Time" Quality Measure Remains Hard to DefineKyra O'Brien, Robert E Burke, Debra Saliba
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 31, 2024
Applying recommendations for diagnostic disclosure of mild cognitive impairment and dementia: Practical guidance for cliniciansKyra O'Brien, Emily A Largent, Jason Karlawish
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthKyra O'Brien, Wheeler Maxwell, Robert Burke, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersAbigail Perelman, Megan Zhang, Cameron Coykendall, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersMegan Zhang, Abigail Perelman, Cameron Coykendall, et al.
Neurology|January 31, 2023
Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease ContinuumEmily A Largent, Joshua D Grill, Kyra O'Brien, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 8, 2026
Study of the utility and impact of a plasma p-tau181 Alzheimer's biomarker (SUITABLE)Kyra O'Brien, Cameron Coykendall, Kristin Harkins, et al.
Journal of General Internal Medicine|January 3, 2024
Determinants of Plasma Alzheimer's Disease Biomarker Use by Primary Care Providers and Dementia SpecialistsKyra O'Brien, Cameron Coykendall, Melanie Kleid, et al.
Pageof 2